New Enterprise Associates

New Enterprise Associates is a venture capital firm founded in 1977 and based in Menlo Park, California, with offices in the United States, India and China. It makes investments across technology and healthcare startups at multiple stages, from seed to growth, including software, cloud, data, internet services, fintech, AI, e-commerce, and enterprise technology, as well as healthcare information technology, life sciences, medical devices, and biopharma. It also considers energy technology and infrastructure opportunities, such as solar, batteries and smart grids. The firm pursues a global approach, with activity in the United States, Asia and other regions, and supports companies through rounds of financing ranging from small to sizable investments as they scale. NEA focuses on building portfolios in software, IT services, consumer technology, and healthcare technology, backing ambitious entrepreneurs across sectors and geographies.

Michael Albert

Associate

Kate Barrett

Partner, Communications

James Buxton MD

Principal

Pamela Clark

General Partner

Vanessa Deng

Associate

Chris Doppman

Managing Director, LP Relations

Jay Graf

Venture Partner

Arjun Jain

Senior Associate

Nick Kline

Partner, LP Relations

Mohamad Makhzoumi

General Partner, Global Head of Healthcare Services

Jake Nunn

Partner

Greg Papadopoulos

Venture Partner

Arno Penzias Ph.D

Venture Partner

Tim Schaller

CFO

George Stamas

Venture Partner

Brad Thawley

Partner, Limited Partner Relations

Lulu Xu

Principal

Edison Zhang

Associate

Past deals in Series B

Vori Health

Series B in 2025
Vori Health offers an integrated medical practice specializing in treating musculoskeletal conditions. Its nationwide, evidence-based approach addresses back, neck, and joint issues through a unique, virtual-first care model. Patients are connected to a collaborative team consisting of a board-certified physician, health coach navigator, and physical therapist for comprehensive care.

Tune Therapeutics

Series B in 2025
Tune Therapeutics develops cell and gene therapies guided by epigenetic programming to treat devastating diseases. The company is building an epigenetic programming platform that enables new pathways for disease treatment by tapping into the epigenome to program biology without altering the DNA sequence. This approach aims to deliver paradigm-changing therapies by modulating gene expression through epigenetic mechanisms rather than editing the genome, expanding options for diseases where conventional treatments have limited efficacy. By integrating epigenetics and cell biology, the company seeks durable, precise interventions that can reprogram cellular states to restore function while minimizing genetic change. The emphasis is on research and development to advance candidates toward clinical use to address severe and unmet medical needs.

858 Therapeutics

Series B in 2024
858 Therapeutics is a biotechnology company specializing in the discovery of small molecule therapeutics for novel targets in oncology and immunology. The company focuses on innovative approaches such as synthetic lethality, innate immunity, and RNA modulation, with its lead program being a PARG inhibitor currently in early clinical development.

PayZen

Series B in 2024
PayZen is a healthcare fintech company that helps patients manage out-of-pocket medical expenses by offering flexible, transparent payment plans and non-recourse financing. The platform enables patients to pay bills over time while helping providers accelerate cash flow and reduce costly collections. It uses AI-powered risk assessment to tailor each plan to the individual patient, supporting affordable payments without upfront burden. Founded in 2019 in San Francisco by Ariel Rosenthal, Itzik Cohen, and Tobias Mezger, PayZen aims to reduce financial barriers to care while enabling providers to focus on delivering services.

Cardurion Pharmaceuticals

Series B in 2024
Cardurion Pharmaceuticals, LLC, established in 2017 and headquartered in Boston, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for heart failure and other cardiovascular diseases. The company is advancing clinical programs that target PDE9 and CaMKII inhibition, utilizing its expertise in cardiovascular signaling pathways to address significant unmet patient needs.

SafeBase

Series B in 2024
SafeBase, Inc. is a San Francisco-based company founded in 2020 that specializes in cloud-based security software aimed at helping organizations establish and enhance their security programs. The company’s offerings include a smart trust center platform that facilitates the sharing of security posture and automates access to sensitive documents. SafeBase provides solutions such as SafeBase Inspected, which features a website badge linking to a custom security status page, as well as custom security checklists and continuous monitoring of security systems. Additionally, the software assists organizations in configuring security policies, thereby enabling them to implement robust security practices effectively.

beehiiv

Series B in 2024
Beehiiv operates an email newsletter platform designed for creators. It facilitates the production, monetization, and expansion of newsletters while enhancing audience engagement and growth. The platform's direct engagement model reduces reliance on cookie-based data.

Lily AI

Series B in 2024
Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.

Metronome

Series B in 2024
Metronome provides billing infrastructure for software companies, facilitating rapid deployment, flexibility, and user-friendly solutions. It enables business and product teams to manage revenue and pricing independently, streamlining workflows and offering customers real-time spending insights.

Comanche Biopharma

Series B in 2024
Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. Its mission is to provide safe, effective, evidence-based, and affordable therapies for treating life-threatening complications of pregnancy.

Perplexity

Series B in 2024
Perplexity is an AI-driven search engine platform that combines large language models with traditional search engines. It uses natural language processing (NLP) and generative AI to provide conversational responses, bridging the gap between conventional search engines and interactive AI assistance.

Second Front Systems

Series B in 2023
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.

Fizz

Series B in 2023
Fizz is an authorized platform designed to enhance community social structures, particularly within institutions. It develops online social media software that facilitates communication and the sharing of ideas, events, and experiences among users. The platform allows individuals to post secret confessions and ask questions within a closed community, promoting social interaction while maintaining anonymity. By leveraging these features, Fizz aims to foster a more connected and engaged community environment.

Sana

Series B in 2023
Sana Labs is a leader in applying artificial intelligence to enhance educational outcomes through personalized learning. The company collaborates with prominent organizations to develop its innovative learning platform, which leverages advanced machine learning techniques. This platform is designed to empower education companies and integrates seamlessly with various applications, allowing employees to access knowledge, communicate, and automate tasks effectively. By offering insights into team strengths, weaknesses, and progress, Sana enables institutions in sectors such as healthcare, finance, and pharmaceuticals to improve their workforce's performance and learning experiences. The interdisciplinary team at Sana comprises experts from diverse fields, contributing to its mission of transforming the future of education.

Weaviate

Series B in 2023
Weaviate is a company that offers an open-source AI-native database and hybrid SaaS platform to build search and recommendation systems. Its vector search engine supports semantic search and integrates with applications via plugins and a console that helps understand data. The platform merges vector and keyword search to enable end-to-end AI-native application development, supporting synchronous, asynchronous, and multi-step data interactions.

Workera

Series B in 2023
Workera is a precision upskilling platform that enables enterprises, governments, and individuals to enhance their technological capabilities in areas such as data science, machine learning, and artificial intelligence. The platform utilizes AI-driven assessments and personalized learning plans to provide targeted mentorship and facilitate skill development. By offering an objective analysis of workforce skills, Workera helps organizations identify and mobilize talent effectively. Its approach includes measuring skills at a granular level, allowing for hyper-personalized learning experiences that drive measurable results. This capability equips organizations with actionable data, enabling them to make informed decisions regarding talent acquisition, mobility, coaching, and mentoring, ultimately addressing the critical skills gap in today's rapidly evolving technological landscape.

Fabric8Labs

Series B in 2023
Fabric8Labs, Inc. is a technology company founded in 2015 and located in La Jolla, California, specializing in non-thermal metal 3D printing. The company has developed a proprietary process that combines stereo-lithography and electro-deposition, providing an innovative alternative to traditional powder bed fusion technologies. This method eliminates the reliance on metal powders, vacuum chambers, and lasers, which significantly reduces manufacturing costs while enhancing material quality. Fabric8Labs' technology allows clients to use cartridges that simplify the additive manufacturing process and facilitate the safe disposal of used salt cartridges, thereby promoting efficiency and sustainability in metal 3D printing.

Crowdbotics

Series B in 2023
Crowdbotics is an application development platform that provides an enterprise-grade solution for building, modernizing and deploying web and mobile applications. It offers a library of production-grade components and a network of on-call experts to help product managers translate ideas into working code, selecting effective components and workflows. The platform handles infrastructure, implementation, maintenance, operations, monitoring and security for the life of a project, and uses artificial intelligence to map application requirements to existing code modules while capturing business logic and developer intent. It supports modernization, onboarding and governance by integrating with current tools and infrastructure, enabling enterprises to modernize legacy systems, reduce development risk and improve engineering efficiency.

Dandelion Energy

Series B in 2022
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

MBX Biosciences

Series B in 2022
MBX Biosciences is a biotechnology company focused on developing therapies for endocrine and metabolic disorders, emphasizing rare endocrine diseases with limited treatment options. It pursues discovery, development, and commercialization of first-in-class peptide therapeutics that modulate glandular hormone signaling. MBX has developed a proprietary Precision Endocrine Peptide platform to engineer peptides with extended time-action profiles and consistent drug exposure, aiming to overcome limitations of traditional peptide therapies and improve disease management. Based in Carmel, Indiana, the company advances novel peptide programs through clinical development to address unmet medical needs in endocrine and metabolic disorders.

Merge

Series B in 2022
Merge simplifies secure data access by offering Unified APIs across key software categories like HRIS, accounting, CRM, and file storage. It handles the entire integration lifecycle, from initial build to maintenance, enabling thousands of companies to unblock sales, reduce churn, accelerate product launch, and save engineering resources.

Theorycraft Games

Series B in 2022
Theorycraft Games operates as an independent game development studio that operates remotely. The company is in process of developing its first game codenamed Loki. Theorycraft was founded in 2020 and is headquartered in Los Angeles, California, United States.

Ledgy

Series B in 2022
Ledgy develops a valuation tracking platform to manage equity capital and employee participation. The platform streamlines vesting plans, phantom programs, and numbered shares, digitizing equity management to provide entrepreneurs and shareholders with clear insights into their capital table, financing rounds, and exit talks. Founded in 2017 in Zurich, Switzerland, Ledgy supports startups and growing companies in planning and communicating equity arrangements for stakeholders.

Snowplow

Series B in 2022
Snowplow is an enterprise-grade event analytics platform that specializes in behavioral data management. It empowers data teams by providing tools to track, contextualize, validate, and model customer interactions on websites and applications. The platform integrates web analytics with various third-party data sources, allowing businesses to gain comprehensive insights into customer behavior. Snowplow's solutions facilitate customer journey analytics, marketing attribution, product analytics, and paywall optimization, addressing complex data challenges and enhancing overall data-driven decision-making for organizations.

Narmi

Series B in 2022
Narmi Inc. is a technology company that specializes in developing online and mobile banking applications for financial institutions across the United States. Founded in 2016 and headquartered in New York, Narmi provides a comprehensive platform that allows regional and community banks and credit unions to attract, engage, and retain customers effectively. The company’s applications facilitate account openings in under 2.5 minutes, while ensuring a secure and user-friendly experience through features such as fraud protection, multi-factor authentication, and transaction monitoring. In addition to banking applications, Narmi also offers services in website design, development, hosting, and content management, helping financial institutions create a dynamic and engaging digital presence.

Wonder

Series B in 2022
Wonder is a technology company that develops an all-in-one gaming platform for Android mobile devices. The platform enables users to play, stream, and share games across devices seamlessly.

Lily AI

Venture Round in 2022
Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.

Assembled

Series B in 2022
Assembled, Inc. is a workforce management platform based in San Francisco, California, founded in 2018. The company specializes in enhancing customer support operations for modern organizations by automating key processes such as contact forecasting, staffing calculations, and productivity reporting. Its platform allows teams to effectively forecast support volumes and develop appropriate staffing plans, eliminating the need for cumbersome spreadsheets and disparate internal tools. Assembled offers an intuitive team calendar that accommodates various time zones and specializations, integrating seamlessly with popular tools like Google Calendar and Slack to facilitate collaboration. Additionally, it provides visibility into support schedules and performance metrics, including response times, across all organizational levels. By streamlining these processes, Assembled empowers organizations to make informed decisions, ultimately improving their customer support capabilities.

Mashgin

Series B in 2022
Mashgin is a California-based developer of AI-driven self-checkout kiosks used in cafeterias, convenience stores, specialty and travel retail. The system uses computer vision, deep learning, and real-time 3D technology to recognize items and handle multiple items in a single scan, speeding up checkout. The kiosks are deployed at hundreds of locations and serve tens of thousands of customers daily.

ForAllSecure

Series B in 2022
ForAllSecure specializes in advanced fuzz testing solutions, leveraging patented technology from Carnegie Mellon University. It partners with Fortune 1000 companies across industries like aerospace and automotive to provide scalable, autonomous security testing that keeps pace with rapid development cycles and frequent deployments.

Thunkable

Series B in 2022
Thunkable is a United States-based no-code platform that enables users to create native mobile applications without writing code. It offers a drag-and-drop interface, built-in templates, and design elements to simplify app development, with online design and instant previews on devices. The platform supports cross-platform deployment to major mobile platforms and enables direct submission to the iOS and Android app stores, allowing individuals and developers to build functional apps without traditional coding.

Smartcar

Series B in 2022
Smartcar develops a platform that enables mobility businesses to integrate their apps with connected vehicles. Its API allows retrieval of vehicle data like location, EV charging status, and remote locking/unlocking, facilitating seamless interactions between users and their cars.

Aquabyte

Venture Round in 2022
Founded in 2017, Aquabyte specializes in developing smart camera systems and machine learning models for aquaculture. Its solutions include real-time sea lice counting, biomass monitoring, appetite detection, and feed optimization, aiming to enhance fish farm efficiency, sustainability, and profitability.

Korro Bio

Series B in 2022
Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.

Mojo Vision

Series B in 2022
Founded in 2015, Mojo Vision specializes in developing and commercializing advanced micro-LED display technology for various applications. The company is renowned for creating the world's smallest dynamic display for augmented reality smart contact lenses. Headquartered in Saratoga, California, Mojo Vision aims to disrupt the $160 billion display industry with its proprietary quantum-dot technology.

Yumi

Series B in 2021
Yumi is a company that specializes in providing science-based meal delivery services for infants and young children. It focuses on producing fresh, nutrient-dense, and low-sugar baby food designed to meet the dietary needs of various age groups. Yumi aims to help parents understand the nutritional value of what they are feeding their children, particularly during the crucial early years of development. By offering a convenient and health-oriented solution, Yumi supports parents in ensuring their children receive optimal nutrition for brain development and overall well-being.

Pair Eyewear

Series B in 2021
Pair Eyewear, Inc. is a New York-based company that specializes in customizable eyeglasses for children. Founded in 2017 by Nathan Kondamuri and Sophia Edelstein, the company offers a unique approach to eyewear by providing base frames and interchangeable top frames that allow kids to express their personal style and interests. By combining functionality with creativity, Pair Eyewear transforms glasses from mere medical devices into a fun and engaging accessory for children. The company's direct-to-consumer model leverages an e-commerce platform, making the purchasing process convenient for parents while enhancing the overall experience for young wearers. Pair Eyewear is committed to offering quality, affordable glasses that are both stylish and practical, featuring hand-polished frames and shatterproof polycarbonate lenses.

Jiandanxinli (aka Simple Psychology)

Series B in 2021
Simple psychology belongs to Beijing Zhujian Technology Co., Ltd. Simple psychology focuses on providing high-quality psychological services.

UNION

Series B in 2021
UNION POS specializes in developing UNION TAB, a customizable iPad-based point of sale software tailored for bars and restaurants. Established in 2009 and headquartered in Austin, Texas, UNION POS focuses on meeting the unique needs of high-volume, high-touch venues. Their system offers a fast and intuitive interface that simplifies reporting and operational processes, allowing users to dedicate more time to customer engagement. The software includes features such as inventory management and loyalty programs, all supported by 24/7 live assistance and competitive processing fees. UNION POS aims to create a seamless experience that enhances operational efficiency while enabling businesses to concentrate on delivering exceptional service.

Contra

Series B in 2021
Contra is a networking platform founded in 2019 by Ben Huffman and Gajus Kuizinas. It connects independent professionals with flexible work opportunities through an exclusive community, enabling freelancers to earn a living on their own terms.

Attest

Series B in 2021
Attest Technologies Ltd., established in 2015 and headquartered in London, UK, operates a global online consumer research platform. It offers businesses real-time, on-demand consumer insights through surveys, enabling them to make data-driven decisions across various aspects such as marketing, product development, and brand tracking. Attest's platform allows direct engagement with over 110 million consumers across 45 countries, providing international research and testing solutions. The company is backed by prominent investors, including NEA, and serves clients aiming to drive predictable growth and fill knowledge gaps.

Embrace

Series B in 2021
Embrace is a developer of a unified observability and error monitoring platform that enables engineers to effectively manage the complexities of mobile applications. The platform provides comprehensive insights by allowing users to access detailed behavioral and technical context, helping teams identify and prioritize issues instantly. Embrace empowers engineers to track user sessions, monitor activities, and analyze data related to app performance, including every view, tap, network request, and memory usage. By eliminating fragmented solutions and guesswork, Embrace enhances the ability of companies to resolve issues quickly and optimize mobile experiences, ultimately fostering the development of better and more impactful mobile applications.

Inkitt

Series B in 2021
Inkitt operates an online community for writers and readers, offering a platform where authors can share and refine their work while gaining insights from readers. The company uses data-driven approaches to identify popular stories and publishes them across various media, aiming to create blockbuster franchises similar to Disney's model.

Rapid Robotics

Series B in 2021
Rapid Robotics is a provider of industrial automation solutions focused on robotic arms and palletizing systems for manufacturing and logistics. The company develops and deploys affordable robotic workcells and software that combine AI and vision-based capabilities to handle a range of palletizing and material-handling tasks. Its offerings enable rapid deployment, often in hours rather than weeks, and aim to lower operating costs while increasing production capacity, efficiency, and quality. Through a Robot-as-a-Service model, Rapid Robotics helps sites scale automation without the burden of ownership or extensive custom programming. Founded in 2019 and headquartered in San Francisco, the company targets manufacturers facing labor shortages and rising fulfillment complexity by delivering flexible, service-driven automation that improves margins and throughput.

Woebot Health

Series B in 2021
Woebot Health is a digital mental healthcare provider that offers a platform designed to deliver personalized support and guidance. Utilizing advanced artificial intelligence and natural language processing, Woebot Health incorporates clinically proven therapeutic techniques into its services. The centerpiece of its offering is Woebot, an engaging relational agent that facilitates continuous, empathic, and user-friendly interactions. This innovative approach allows individuals and organizations to access effective mental health support seamlessly, fitting into daily life and providing help whenever needed. Woebot Health aims to enhance mental well-being through scalable digital tools, making mental health resources more accessible to a broad audience.

Block Renovation

Series B in 2021
Block Renovation operates a renovation platform that unites design, sourcing, and construction within a single process to simplify home makeovers. The company combines architect-grade design, construction labor, and materials into a streamlined experience, enabling homeowners to plan, design, and build renovations with greater certainty around outcomes, quality, price, and timeline. By integrating design, sourcing, and project management under one roof, Block Renovation aims to improve the renovation journey for homeowners and provide contractors with a clearer, more efficient workflow.

Shape Therapeutics

Series B in 2021
Shape Therapeutics, Inc. is a biotechnology company focused on RNA-editing gene therapy for various medical conditions, including neurodegenerative disorders, oncology, metabolic diseases, and rare genetic disorders. Founded in 2018 and headquartered in Seattle, Washington, the company utilizes its proprietary RNAfix technology to edit RNA using the body’s natural cellular machinery. This approach minimizes risks associated with immunogenicity, cellular toxicity, and unintended DNA editing. Shape Therapeutics is dedicated to advancing its innovative platforms for payload, delivery, and manufacturing to enable the development of effective treatments, aiming to address critical health challenges and improve patient outcomes.

Spiras Health

Series B in 2021
Spiras Health operates a healthcare service that delivers specialized care to patients' homes for those managing complex chronic conditions. Their multidisciplinary clinical team offers services enhanced by telehealth, digital communications, and remote monitoring, aiming to improve patients' quality of life and reduce unnecessary hospitalizations.

Metabase

Series B in 2021
Founded in 2014, Metabase is an open-source analytics and business intelligence application that enables users to create dashboards and share insights. Its platform offers professional services such as managed hosting and custom implementation assistance.

Timescale

Series B in 2021
Timescale develops an open-source time-series SQL database, TimescaleDB, designed for scale and complex queries. It integrates directly into query planning and execution engines to optimize performance, enabling clients to organize, store, analyze, and interpret time-series and machine data.

Genies

Series B in 2021
Genies empowers individuals to create personalized digital avatars for expression across social media and messaging platforms. It offers tools for users to design avatars, avatar fashion lines, worlds, and interactive experiences, enabling brands to drive engagement through exclusive digital goods.

Affinia Therapeutics

Series B in 2021
Affinia Therapeutics develops adeno-associated virus (AAV) gene therapies for muscular and central nervous system diseases. The company uses an AAV vector design platform built on synthetic and systems biology, high-throughput screening, and tissue- and single-cell-resolution analyses to create vectors with improved properties. It leverages sequencing, artificial intelligence, and structural modeling to enable rational design of therapies. Headquartered in Waltham, Massachusetts, Affinia Therapeutics was founded in 2019 and targets diseases with significant unmet needs in muscle and CNS.

Strive Health

Series B in 2021
Strive Health, LLC is a company focused on providing comprehensive solutions for chronic kidney disease. Founded in 2018 and based in Denver, Colorado, Strive Health operates dialysis centers and employs advanced predictive analytics to enhance patient care. The company offers a high-touch, technology-enabled clinical model that supports patients throughout their healthcare journey, from primary care engagement to dialysis treatment. By utilizing comparative and predictive data, Strive Health aims to identify at-risk patients and transform the management of kidney disease, promoting earlier intervention and increasing the adoption of home dialysis. This innovative approach not only improves patient outcomes but also seeks to reduce inpatient utilization, ultimately enhancing the overall experience for individuals dealing with chronic kidney conditions.

Dandelion Energy

Series B in 2021
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

WireWheel

Series B in 2021
WireWheel, Inc. is a software company specializing in data privacy management solutions, designed to assist organizations in complying with various data protection regulations such as the EU GDPR and HIPAA. Established in 2016 and headquartered in Arlington, Virginia, WireWheel offers a cloud-based platform that integrates machine learning and data science to streamline privacy program management and subject rights request handling. The platform facilitates the automatic mapping of public cloud assets and aids in managing third-party relationships, enabling organizations to effectively navigate compliance obligations while maximizing the value of their data assets. WireWheel's innovative approach positions its clients to operationalize privacy effectively within their enterprises.

Spyglass Ophthalmics

Series B in 2021
Spyglass Ophthalmics, Inc. is a company based in Mission Viejo, California, specializing in the development of ophthalmic therapeutic devices. Founded in 2019, Spyglass focuses on creating innovative solutions to enhance vision and eye care for patients. The company's products target unmet needs in areas such as cataract treatment, lens replacement, and other chronic ophthalmic diseases. By providing these devices, Spyglass aims to ensure that patients receive quality eye treatment at an affordable cost.

Senti Biosciences

Series B in 2021
Senti Biosciences is a biotechnology company focused on synthetic biology. It develops gene circuit platforms to engineer therapeutics, with a focus on improving precision and control in cancer treatments.

Reneo Pharmaceuticals

Series B in 2020
Reneo Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company based in San Diego, California, dedicated to developing therapies for patients with rare genetic mitochondrial diseases. These conditions are characterized by deficits in cellular metabolism and energy production, often leading to significant health challenges. The company is focused on creating treatments that improve mitochondrial function, preserve muscle integrity, and enhance the overall quality of life for affected individuals. Its lead product candidate, REN001, is an oral medication designed to modulate genes critical to the production of adenosine triphosphate (ATP), the primary energy source for cellular processes. Founded in 2014, Reneo aims to address the unmet needs of patients suffering from orphan metabolic diseases linked to mitochondrial dysfunction.

Beyond Identity

Series B in 2020
Beyond Identity, Inc. is a New York-based company that specializes in cloud-native passwordless identity management solutions. Founded in 2019, it aims to enhance digital security by replacing traditional passwords with secure, X.509-based certificates. This innovative approach creates a robust Chain of Trust, incorporating user and device identity along with a real-time assessment of device security for adaptive authentication and authorization. Beyond Identity's platform facilitates frictionless login experiences through biometric authentication and seamless integration with Single Sign-On (SSO) systems, catering to employees, contractors, and customers alike. By eliminating the use of passwords, the company helps organizations mitigate risks associated with credential-stuffing attacks and streamline their authentication processes, ultimately enabling greater business agility and cost efficiency.

National Resilience

Series B in 2020
National Resilience, also known as Resilience, is a biopharmaceutical manufacturing and technology company that provides end-to-end manufacturing and development solutions for diverse modalities, including cell and gene therapies, viral vectors, vaccines, and proteins. It actively invests in developing new manufacturing technologies to expand access to complex medicines and supports partners through the full lifecycle from development to commercial supply. The company was incorporated in 2020 and is based in La Jolla, California.

Pulumi Corporation

Series B in 2020
Founded in 2017, Pulumi Corporation operates an infrastructure-as-code platform for developing cloud software. It offers Pulumi SDK, an open-source tool enabling developers to create, deploy, and manage cloud applications and infrastructure using code. The company also provides a web console for collaborative delivery and management of cloud apps and infrastructure across public, private, or hybrid environments.

Outrider

Series B in 2020
Outrider develops autonomous electric trucks and management software for logistics hubs. Its technology automates yard operations, enhancing safety and efficiency for large enterprises.

Forethought Technologies

Series B in 2020
Founded in 2017, Forethought Technologies develops AI models for question-answering and information retrieval, embedding them into employee workflows. Its flagship product, Agatha Answers, is a smart agent that enhances customer support teams' efficiency by resolving common queries instantly.

Anyscale

Series B in 2020
Anyscale develops and operates distributed programming platforms for simplifying distributed AI development. It offers Ray, an open-source framework enabling software developers and machine learning engineers to scale applications effortlessly from a laptop to the cloud.

Matroid

Series B in 2020
Matroid, Inc. is a Palo Alto-based company that specializes in computer vision technology. Founded in 2016, it offers an intuitive platform that enables users to create and deploy custom computer vision detectors without the need for programming. These detectors can identify people, objects, and events in visual media, making it easier for clients to monitor live streams, search recorded videos, and receive real-time notifications about specific occurrences. Matroid serves a diverse range of industries, including construction, manufacturing, security, media, and retail, by providing solutions that enhance efficiency and situational awareness through advanced visual recognition capabilities.

Illusive Networks

Series B in 2020
Illusive Networks Ltd. is a cybersecurity company that specializes in deception-based solutions designed to protect enterprise systems from cyber threats. Founded in 2014 and headquartered in Tel Aviv, Israel, with an additional office in New York, Illusive aims to reduce cyber risk by shrinking the attack surface and hindering an attacker's lateral movement within the network. Its platform creates a hostile environment for potential intruders by replacing vulnerable connections with deceptive alternatives, enabling the identification of attackers and providing actionable forensic insights. The company's offerings include a range of services such as compliance support, insider threat defense, and cloud security, as well as tools like the Illusive Networks Management Platform and Attack Surface Manager. Illusive serves a diverse clientele across various sectors, including financial services, healthcare, legal, manufacturing, retail, and technology, and is recognized for its advanced detection of persistent threats and targeted attacks.

Monte Rosa Therapeutics

Series B in 2020
Monte Rosa Therapeutics is a biotechnology company focused on cancer therapeutics that target protein degradation pathways. It specializes in developing molecular glue degraders, a class of small molecules that direct disease-relevant proteins to degradation by the cell's natural machinery. The company uses its QuEEN platform, incorporating artificial intelligence and proprietary experimental tools, to identify target proteins for degradation by molecular glue degraders. It maintains a diverse library of more than 50,000 molecules and advancing its pipeline, including MRT-2359, a candidate that targets the translation termination factor GSPT1 for potential use in MYC-driven tumors.

Maisonette

Series B in 2020
Founded in 2016, Maisonette is an online marketplace specializing in baby and children's products. It curates and offers a diverse range of high-quality apparel, accessories, toys, furniture, and home decor for children aged 0-12 through its global network of brands and boutiques.

Attest

Venture Round in 2020
Attest Technologies Ltd., established in 2015 and headquartered in London, UK, operates a global online consumer research platform. It offers businesses real-time, on-demand consumer insights through surveys, enabling them to make data-driven decisions across various aspects such as marketing, product development, and brand tracking. Attest's platform allows direct engagement with over 110 million consumers across 45 countries, providing international research and testing solutions. The company is backed by prominent investors, including NEA, and serves clients aiming to drive predictable growth and fill knowledge gaps.

Mojo Vision

Series B in 2020
Founded in 2015, Mojo Vision specializes in developing and commercializing advanced micro-LED display technology for various applications. The company is renowned for creating the world's smallest dynamic display for augmented reality smart contact lenses. Headquartered in Saratoga, California, Mojo Vision aims to disrupt the $160 billion display industry with its proprietary quantum-dot technology.

Bestow

Series B in 2020
Bestow Inc., established in 2016 and based in Dallas, Texas, operates as a digital life insurance company. It provides life insurance services to individuals, leveraging data-driven technology applications and algorithmic underwriting to assess risks efficiently. The company partners with top carriers to enhance processes from origination to administration, aiming to increase financial stability for all.

ARRIS

Series B in 2020
ARRIS specializes in developing additive molding technology for manufacturing large-scale 3D-aligned continuous fiber thermoplastic composite parts. Its innovative process combines aligned fibers, electronics, and metallic components within topology-optimized structures, serving industries such as aerospace, automotive, and consumer products.

Pager

Series B in 2020
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.

Akouos

Series B in 2020
Akouos is a biotechnology company focused on precision genetic medicine to restore and preserve hearing. Based in Boston, it develops gene therapies using a proprietary adeno-associated viral vector platform and delivery approaches to treat sensorineural hearing loss in genetically defined populations. The company's lead program, AK-OTOF, targets hearing loss caused by mutations in the OTOF gene. Akouos pursues research and development across gene-based interventions aimed at improving auditory function and long-term sensory outcomes. It has collaborations with academic and industry partners, including Massachusetts Eye and Ear and Lonza, to advance discovery and manufacturing capabilities. Founded in 2016, Akouos addresses unmet clinical needs in auditory health by seeking to restore physiologic hearing through targeted genetic therapies.

Berkshire Grey

Series B in 2020
Berkshire Grey, Inc. is a technology company specializing in the development of artificial intelligence-driven robotic and automated material handling systems. Founded in 2013 and based in Lexington, Massachusetts, the company focuses on automating tasks traditionally performed by humans in commercial settings, enhancing efficiency in fulfillment, supply chain, and logistics operations. Its offerings include a range of robotic solutions, such as autonomous picking and sorting systems, mobile robotic units, and dynamic parcel sortation technologies. Additionally, Berkshire Grey provides electromechanical solutions that incorporate vision systems and advanced scanning technologies. By leveraging AI, computer vision, and machine learning, the company's systems enable clients to achieve higher accuracy and throughput speeds while managing diverse product assortments. The majority of its revenue is generated from North America, positioning Berkshire Grey as a significant player in the automation landscape.

Flow Commerce

Series B in 2019
Flow Commerce, Inc. is a technology company that specializes in cross-border e-commerce solutions, facilitating international sales for online merchants. Founded in 2015 and headquartered in Hoboken, New Jersey, with an office in Dublin, Ireland, Flow provides a versatile platform that allows e-commerce businesses to easily configure their global supply chain and meet overseas demand. The platform addresses the complexities of international commerce by offering tools for multi-currency pricing, rapid shipping, international payment processing, tax management, and logistics. Flow's solution can be utilized as a comprehensive end-to-end system or as modular components, making it accessible for e-commerce companies of all sizes. By simplifying the buying and selling process across borders, Flow Commerce enhances the overall experience for both merchants and consumers.

IonQ

Series B in 2019
IonQ is a quantum computing company that develops general-purpose quantum information processors based on trapped-ion technology. Its approach enables qubit replication, optical networkability, and optimized algorithms to support scalable quantum computation beyond classical capabilities. Founded in 2015 and based in College Park, Maryland, IonQ offers access to its quantum computers through cloud platforms, providing quantum-computing-as-a-service to a broad user base and select customers through its own cloud service. Revenue streams include QCaaS arrangements and related consulting and co-development contracts for algorithm design and system integration.

Instabase

Series B in 2019
Instabase, Inc. is a technology company based in San Francisco, California, founded in 2015. It specializes in developing a platform that automates document processing workflows and analyzes unstructured data. The platform integrates various capabilities, including optical character recognition, data classification and extraction, and natural language processing, allowing organizations across sectors such as insurance, finance, and healthcare to streamline operations and improve decision-making. Additionally, Instabase provides a developer kit that enables the creation of customized business applications, helping institutions embed artificial intelligence into their systems and processes. Through its innovative solutions, Instabase aims to address significant business challenges and facilitate transformational outcomes for its clients.

Sisu

Series B in 2019
Sisu is a decision intelligence engine that allows users to efficiently and comprehensively utilize their cloud data. Companies such as Mastercard, Autodesk, Samsung, Upwork, Wayfair, Equinox, Udacity, and Gusto leverage Sisu to enhance their customer experiences, increase revenue growth, and reduce incident rates.

Arcellx

Series B in 2019
Arcellx is a clinical-stage biotechnology company developing immunotherapies and cell therapies for cancer and other serious diseases. It seeks to make cell therapies safer, more effective, and more broadly accessible. Its lead candidate CART-ddBCMA is in a Phase 1 trial for relapsed or refractory multiple myeloma and has FDA Fast Track, Orphan Drug, and Regenerative Medicine Advanced Therapy designations. The company is also advancing ARC-SparX, a dosable and controllable CAR-T platform, into clinical programs ACLX-001 for relapsed or refractory multiple myeloma and ACLX-002 for relapsed or refractory acute myeloid leukemia. Arcellx's pipeline covers multiple myeloma, acute myeloid leukemia, and other cancer indications, with research extending into additional oncology areas and other serious diseases.

Stockwell

Series B in 2019
Stockwell AI, Inc. operates automated retail stores that provide everyday essentials in convenient locations such as offices, apartments, gyms, and college campuses. Founded in 2016 and based in Oakland, California, the company utilizes advanced technology, including computer vision and machine learning, to facilitate transactions through its Bodega application. This app allows users to link their payment methods and easily access items within the automated stores. Stockwell AI focuses on enhancing the retail experience by combining the convenience of online shopping with the immediacy of in-person purchases. The company offers smart vending machines stocked with non-perishable grocery items, aiming to save consumers time and reduce the costs associated with traditional shopping methods. In July 2018, Stockwell AI changed its name from Bodega AI and now operates as a subsidiary of 365 Retail Markets, LLC.

Built Robotics

Series B in 2019
Built Robotics develops automation technology for the construction industry by turning heavy equipment into autonomous robots with AI-guided software that integrates sensors such as GPS, cameras, and Lidar. The systems retrofit onto earthmoving equipment to enable autonomous operation on job sites, supporting projects such as wind farms, oil and gas pipelines, mining, and housing developments, and they are used to automate repetitive tasks in solar projects to accelerate the transition to clean energy.

Nkarta Therapeutics

Series B in 2019
Nkarta Therapeutics is a clinical-stage biopharmaceutical company focused on developing allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company aims to harness the inherent power of NK cells to target and destroy tumor cells, offering a potent and better-tolerated alternative to traditional T-cell therapies for a broad range of cancer indications.

Burrow

Series B in 2019
Burrow, Inc. is a New York-based company that designs, manufactures, and supplies luxury furniture for residential use. Founded in 2016, Burrow specializes in creating easy-to-move and customizable seating options such as sofas, sectionals, loveseats, and armchairs, as well as tables, rugs, and various accessories. The furniture is crafted from sustainably-sourced hardwood and features non-toxic, scratch- and stain-resistant fabrics. Burrow aims to provide customers with comfortable and stylish furnishing alternatives while avoiding traditional retail markups. The company operates showrooms in several states, including Washington, Massachusetts, Texas, and California, and also sells its products online. Additionally, Burrow has a manufacturing facility located in Mexico City, Mexico.

Intelligence Node

Series B in 2019
Intelligence Node is a real-time retail price intelligence platform that empowers businesses to drive product-level profitability and grow margins using data-driven competitive insights. It offers an intuitive user interface powered by proprietary AI-driven algorithms, providing unmatched pricing accuracy from the world's largest dataset.

Nuvolo

Series B in 2019
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform designed to support the lifecycle management of assets in various sectors, including healthcare, manufacturing, and facilities management. Founded in 2013 and headquartered in Paramus, New Jersey, Nuvolo innovates on the ServiceNow platform to provide a user-friendly experience for mobile and online users. The company’s solutions encompass implementation, support, tracking, reporting, and analytics, aimed at optimizing operational efficiency and improving asset management. Nuvolo also emphasizes security, workflow automation, and accurate inventory data, making it a comprehensive choice for businesses looking to enhance their asset management capabilities. With additional offices in London, Sofia, and Pune, Nuvolo maintains a global presence through strategic partnerships with firms such as KPMG and Unisys.

One Concern

Series B in 2019
One Concern develops an AI-based platform that helps governments prepare for and respond to natural disasters. Its predictive analytics engine creates post-disaster damage maps, provides daily situational reports, and offers planning modules. The company focuses on earthquakes, hurricanes, floods, fires, and chronic stresses like poverty and climate change.

Sitetracker

Series B in 2019
Sitetracker is a SaaS platform optimizing critical infrastructure lifecycle management. It enables efficient planning, deployment, maintenance, and growth of capital asset portfolios via AI, automation, and analytics.

Evident

Series B in 2019
Evident is a global leader in business credentialing, operating in over 100 countries. Its platform connects insurers, enterprises, and businesses, verifying credentials to meet compliance standards using advanced AI technology.

Mejuri

Series B in 2019
Founded in Toronto, Canada in 2015, Mejuri is a fine jewelry company that offers high-quality, ethically sourced products at affordable prices. It works directly with top jewelers to create exclusive designs and delivers new collections weekly through its direct-to-consumer e-commerce platform.

Lyric

Series B in 2019
Lyric Hospitality, Inc. is a technology-driven company that specializes in short-term rentals and hospitality services tailored for business travelers. Founded in 2014 and headquartered in San Francisco, California, Lyric operates a booking platform designed to provide a professional and enjoyable experience that exceeds traditional vacation rentals. The company offers locally inspired rental properties that combine the comforts of home with the reliability of a hotel. Utilizing an application called Tidy, Lyric effectively manages room cleanings and ensures high standards of service. Additionally, the platform incorporates data analytics to optimize pricing strategies and enhance overall performance, catering to the evolving needs of modern travelers.

Gen.G esports

Series B in 2019
Gen.G esports is a prominent professional esports organization founded in 2017, with its headquarters in Seoul, South Korea, and additional offices in Los Angeles and Shanghai. The organization is known for bridging the esports markets in the United States and Asia, operating top teams in renowned games like Overwatch and League of Legends, and featuring a celebrated all-female Fortnite team. Gen.G has achieved significant recognition, including being ranked among the world's most valuable esports companies. Its teams have won seven global championships, reflecting their competitive prowess. Beyond team management, Gen.G offers a range of services such as coaching, training, and business development, while also creating platforms for global brands to engage with gaming fans. The company is committed to fostering inclusivity in esports through initiatives like #TeamBumble and the Gen.G Elite Esports Academy, which integrates academic programs with esports training. Gen.G's mission emphasizes leveraging the power of gaming to empower both fans and athletes in their pursuits, establishing it as a leader in the evolving landscape of sports entertainment.

Cleo

Series B in 2019
Cleo Labs, Inc. is a family support platform that offers pregnancy consultancy and parenthood guidance services to working parents. The company provides a range of consultation services, including lactation support, birth preparation, child wellness, and sleep consulting, as well as career coaching and immediate post-birth assistance. Cleo's mobile application connects families with certified care practitioners, facilitating their journey from fertility through parenting children up to age five. By partnering with employers, Cleo aims to enhance workplace culture, improve employee retention, and foster diverse and inclusive environments. The company operates globally, serving clients in over 50 countries and has collaborated with notable organizations such as eBay and LinkedIn. Founded in 2016 and headquartered in San Francisco, Cleo was previously known as Instacare Group, Inc. before rebranding in 2018.

Imara

Series B in 2019
Imara, Inc. is a clinical-stage biopharmaceutical company based in Boston, Massachusetts, that specializes in developing and commercializing therapeutics for patients with rare genetic disorders of hemoglobin. Founded in 2016, the company is advancing IMR-687, an oral, once-daily therapeutic designed to treat sickle cell disease and beta-thalassemia. IMR-687 is a highly selective small molecule inhibitor of PDE9, engineered to have a multimodal mechanism of action that impacts various cell types, including red blood cells and white blood cells, as well as adhesion mediators. Through its innovative approach, Imara aims to provide disease-modifying treatments for individuals affected by hemoglobinopathies.

Drop

Series B in 2019
Drop is a consumer rewards platform that uses machine learning to match shoppers with over 400 partner brands, enabling them to earn points, discounts, and cashback on purchases. The service encourages repeat shopping by offering instant rewards and personalized offers. Headquartered in Toronto, Drop serves more than 4 million members across North America and the UK, aiming to improve everyday consumer experiences through its personalized commerce platform.

Oyster Point

Series B in 2019
Oyster Point Pharma, Inc., established in 2015 and headquartered in Princeton, New Jersey, is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for ocular surface diseases. Its lead product candidate, OC-01, is a nasal spray formulated as a highly selective nicotinic acetylcholine receptor (nAChR) agonist, currently in Phase III trials for treating the signs and symptoms of dry eye disease, a chronic condition affecting over 30 million Americans. OC-01's novel mechanism of action stimulates tear production by activating the trigeminal parasympathetic pathway, re-establishing tear film homeostasis.

Tulip Interfaces

Series B in 2019
Tulip Interfaces is a technology company that creates shop‑floor applications for the manufacturing sector. Its no‑code platform integrates sensor data, digital work instructions, real‑time visualization, and operator inputs to connect existing equipment and streamline operations. The solution is used by firms in consumer electronics, pharmaceuticals, apparel, medical devices, aerospace, defense, automotive, and contract manufacturing to improve productivity, quality, and operational visibility. Founded in 2012, the company is headquartered in Somerville, Massachusetts.

KONUX

Series B in 2019
KONUX GmbH is a German company based in Munich, founded in 2014, that specializes in developing Industrial Internet of Things (IIoT) solutions for railway and industrial applications. The company integrates smart sensor systems with artificial intelligence-driven analytics to provide real-time monitoring of asset and infrastructure conditions, enabling predictive maintenance and enhancing operational efficiency. KONUX's offerings include switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and customized hardware solutions. By leveraging machine learning and IoT technologies, KONUX aims to transform railway operations, making them more sustainable, reliable, and cost-effective. The company has expanded its footprint across Europe and Asia and has gained recognition as one of the most innovative startups globally, underscoring its commitment to modernizing transportation systems.

Aetion

Series B in 2019
Aetion is a New York‑based company that builds a real‑world evidence platform. It aggregates claims, electronic health records, registries and clinical trial data to generate analytics that help payers, providers, biopharma and medical device firms assess the effectiveness and value of treatments. The platform’s rapid‑cycle analytics enable real‑time collaboration between payers, providers and life‑science companies, supporting value‑based care decisions. Founded in 2012 by Harvard Medical School faculty and data scientists, it has partnerships with McKesson and receives backing from major venture investors. The platform is used worldwide by health‑economists, epidemiologists and biostatisticians for database analytics and comparative‑effectiveness research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.